Fresenius Medical Care AG & Co. KGaA (XETRA:FME) — Stock Price

€42.31 EUR
▲ 0.62% today

Fresenius Medical Care AG & Co. KGaA (XETRA:FME) is currently trading at €42.31 EUR, up 0.62% today. Over the past 52 weeks, shares have ranged between €34.72 and €47.51. This page tracks Fresenius Medical Care AG & Co. KGaA's live share price on the XETRA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Fresenius Medical Care AG & Co. KGaA (FME) total market value.

Fresenius Medical Care AG & Co. KGaA (FME) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Fresenius Medical Care AG & Co. KGaA's daily closing share price and trading volume on the XETRA exchange over the past year, giving a clear view of recent price momentum and liquidity.

Fresenius Medical Care AG & Co. KGaA Income Statement — Revenue, Profit & Earnings by Year

Fresenius Medical Care AG & Co. KGaA's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue €19.63 Billion €19.34 Billion €19.45 Billion €19.40 Billion €17.62 Billion
Cost of Revenue €14.60 Billion €14.58 Billion €14.53 Billion €14.50 Billion €12.54 Billion
Gross Profit €5.03 Billion €4.76 Billion €4.93 Billion €5.31 Billion €5.08 Billion
Research & Development €158.00 Million €183.49 Million €231.97 Million €228.62 Million €221.00 Million
SG&A €3.03 Billion €2.37 Billion €2.39 Billion €2.37 Billion €3.10 Billion
Total Operating Expenses €3.19 Billion €3.36 Billion €3.56 Billion €3.38 Billion €3.32 Billion
Operating Income €1.84 Billion €1.39 Billion €1.37 Billion €1.54 Billion €301.32 Million
EBITDA €3.34 Billion €3.21 Billion €2.93 Billion €3.22 Billion €3.42 Billion
EBIT €1.84 Billion €1.46 Billion €1.32 Billion €1.38 Billion €1.83 Billion
Interest Expense €385.00 Million €407.04 Million €424.64 Million €360.00 Million €353.00 Million
Income Before Tax €1.51 Billion €1.06 Billion €1.03 Billion €1.22 Billion €1.57 Billion
Income Tax Expense €321.00 Million €316.06 Million €300.56 Million €324.95 Million €353.00 Million
Net Income €978.00 Million €537.91 Million €499.00 Million €673.40 Million €969.31 Million

Fresenius Medical Care AG & Co. KGaA Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Fresenius Medical Care AG & Co. KGaA's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets €31.00 Billion €33.57 Billion €33.93 Billion €35.75 Billion €34.37 Billion
Total Current Assets €7.90 Billion €7.92 Billion €8.70 Billion €8.20 Billion €7.97 Billion
Cash & Equivalents €669.42 Million €342.86 Million €324.43 Million €362.77 Million €556.52 Million
Short-term Investments €127.54 Million €295.63 Million €136.29 Million €169.98 Million €136.36 Million
Net Receivables €3.14 Billion €3.92 Billion €4.06 Billion €3.72 Billion €3.58 Billion
Inventory €2.14 Billion €2.07 Billion €2.18 Billion €2.30 Billion €2.04 Billion
Property, Plant & Equipment €6.50 Billion €7.26 Billion €7.45 Billion €8.34 Billion €8.55 Billion
Goodwill €13.57 Billion €15.17 Billion €14.65 Billion €15.79 Billion €14.36 Billion
Total Liabilities €16.72 Billion €17.80 Billion €19.10 Billion €20.30 Billion €20.39 Billion
Total Current Liabilities €6.25 Billion €5.66 Billion €6.11 Billion €6.47 Billion €7.26 Billion
Long-term Debt €5.69 Billion €6.26 Billion €6.96 Billion €7.17 Billion €6.65 Billion
Net Debt €12.10 Billion €9.83 Billion €10.65 Billion €11.94 Billion €11.84 Billion
Total Stockholder Equity €13.31 Billion €14.58 Billion €13.62 Billion €15.45 Billion €13.98 Billion
Retained Earnings €12.21 Billion €11.27 Billion €10.92 Billion €10.71 Billion €10.83 Billion

Fresenius Medical Care AG & Co. KGaA Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Fresenius Medical Care AG & Co. KGaA generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow €2.68 Billion €2.39 Billion €2.63 Billion €2.17 Billion €2.49 Billion
Capital Expenditures €915.37 Million €699.36 Million €684.60 Million €1.41 Billion €1.68 Billion
Free Cash Flow €1.77 Billion €1.69 Billion €1.94 Billion €756.00 Million €806.00 Million
Investing Cash Flow €-693.55 Million €-84.94 Million €-544.23 Million €-734.73 Million €-1.20 Billion
Financing Cash Flow €-1.43 Billion €-2.57 Billion €-1.86 Billion €-1.62 Billion €-1.02 Billion
Dividends Paid €-422.51 Million €-349.16 Million €-328.62 Million €395.56 Million €392.45 Million
Stock-Based Compensation — — €32.52 Million €-5.87 Million €-1.69 Billion
Depreciation €1.46 Billion €1.74 Billion €1.75 Billion €1.84 Billion €1.62 Billion
Change in Cash €418.93 Million €-241.90 Million €153.44 Million €-207.87 Million €400.12 Million

Fresenius Medical Care AG & Co. KGaA Earnings History — EPS Actual vs. Analyst Estimates

Track Fresenius Medical Care AG & Co. KGaA's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Aug 04, 2026 — 0.99 —
May 05, 2026 0.91 1.03 -11.65%
Feb 24, 2026 1.14 -2.59 +144.02%
Nov 04, 2025 1.10 1.04 +5.77%
Aug 05, 2025 0.77 4.08 -81.13%
May 06, 2025 0.84 0.60 +40.00%
Feb 24, 2025 0.91 1.04 -12.50%
Nov 05, 2024 0.82 3.25 -74.77%